Company Data

Adaptive Biotechnologies Corporation

Ticker
ADPT
Current Price
$8.33 -2.23%
Market Cap
$1.2B
Price Target
Refer to Report
Volume
2.0M
52wk Range
$2.28 - $8.56
Advanced Market Data

Overview

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy